Chilton Capital Management LLC Novartis Ag Transaction History

Chilton Capital Management LLC

  • $2.19 Billion
  • Q2 2024

A detailed history of Chilton Capital Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Chilton Capital Management LLC holds 10,770 shares of NVS stock, worth $1.23 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,770
Previous 11,388 5.43%
Holding current value
$1.23 Million
Previous $1.1 Million 4.09%
% of portfolio
0.05%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
SELL
$92.57 - $107.37 $57,208 - $66,354
-618 Reduced 5.43%
10,770 $1.15 Million
Q1 2024

May 07, 2024
BUY
$95.27 - $108.47 $67,451 - $76,796
708 Added 6.63%
11,388 $1.1 Million
Q4 2023

Jan 18, 2024
SELL
$92.27 - $101.54 $922 - $1,015
-10 Reduced 0.09%
10,680 $1.08 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $5,020 - $5,571
-53 Reduced 0.49%
10,690 $1.09 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $2,960 - $3,357
-32 Reduced 0.3%
10,743 $1.08 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $73,387 - $85,106
-917 Reduced 7.84%
10,775 $991,000
Q4 2022

Feb 14, 2023
BUY
$75.55 - $92.52 $14,430 - $17,671
191 Added 1.66%
11,692 $1.06 Million
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $87,069 - $101,832
1,167 Added 11.29%
11,501 $874,000
Q2 2022

Aug 16, 2022
SELL
$80.52 - $93.75 $7,407 - $8,625
-92 Reduced 0.88%
10,334 $874,000
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $181,449 - $205,254
2,265 Added 27.75%
10,426 $914,000
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $32,677 - $36,133
-410 Reduced 4.78%
8,161 $714,000
Q3 2021

Nov 04, 2021
BUY
$81.78 - $95.14 $134,855 - $156,885
1,649 Added 23.82%
8,571 $701,000
Q2 2021

Aug 16, 2021
SELL
$85.24 - $94.15 $11.6 Million - $12.8 Million
-135,564 Reduced 95.14%
6,922 $632,000
Q1 2021

May 12, 2021
SELL
$83.5 - $98.47 $698,728 - $823,996
-8,368 Reduced 5.55%
142,486 $12.2 Million
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $11,242 - $13,597
-144 Reduced 0.1%
150,854 $14.2 Million
Q3 2020

Nov 13, 2020
BUY
$82.14 - $91.0 $837,828 - $928,200
10,200 Added 7.24%
150,998 $13.1 Million
Q2 2020

Aug 11, 2020
BUY
$80.93 - $91.1 $454,179 - $511,253
5,612 Added 4.15%
140,798 $12.3 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $328,898 - $460,792
4,654 Added 3.57%
135,186 $11.1 Million
Q4 2019

Feb 14, 2020
SELL
$84.35 - $95.37 $39,307 - $44,442
-466 Reduced 0.36%
130,532 $12.4 Million
Q3 2019

Nov 15, 2019
BUY
$85.54 - $94.26 $24,464 - $26,958
286 Added 0.22%
130,998 $11.4 Million
Q2 2019

Aug 13, 2019
SELL
$75.4 - $92.8 $122,600 - $150,892
-1,626 Reduced 1.23%
130,712 $11.9 Million
Q1 2019

May 14, 2019
BUY
$75.32 - $86.15 $165,252 - $189,013
2,194 Added 1.69%
132,338 $12.7 Million
Q4 2018

Feb 12, 2019
BUY
$73.66 - $82.02 $303,626 - $338,086
4,122 Added 3.27%
130,144 $11.2 Million
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $146,063 - $168,952
-2,182 Reduced 1.7%
126,022 $10.9 Million
Q2 2018

Oct 10, 2018
BUY
$64.91 - $73.36 $1.83 Million - $2.06 Million
28,117 Added 28.09%
128,204 $9.67 Million
Q2 2018

Aug 14, 2018
SELL
$64.91 - $73.36 $1.66 Million - $1.88 Million
-25,588 Reduced 20.36%
100,087 $7.56 Million
Q1 2018

Oct 09, 2018
BUY
$70.39 - $84.15 $1.96 Million - $2.34 Million
27,790 Added 28.39%
125,675 $10.1 Million
Q1 2018

May 14, 2018
BUY
$70.39 - $84.15 $6.59 Million - $7.88 Million
93,615 Added 2192.39%
97,885 $7.91 Million
Q4 2017

Feb 13, 2018
BUY
$72.33 - $77.64 $19,746 - $21,195
273 Added 6.83%
4,270 $359,000
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $296,337 - $308,848
3,997
3,997 $343,000

Others Institutions Holding NVS

# of Institutions
1,426
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $246B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Chilton Capital Management LLC Portfolio

Follow Chilton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email